One model is represented by GTL-16_Res, generated by prolonged in vitro treatment of the GTL-16 gastric cancer cell line with the anti-MET Tyrosine Kinase Inhibitor (TKI) PHA-665752 [28]. This evidence concerns the gene MET and gastric cancer.